Detalhe da pesquisa
1.
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
N Engl J Med
; 384(3): 238-251, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332778
2.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med
; 385(13): 1184-1195, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347950
3.
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
N Engl J Med
; 385(23): e81, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587383
4.
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus.
J Infect Dis
; 225(10): 1765-1772, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507266
5.
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.
Clin Infect Dis
; 75(1): e380-e388, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219277
6.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
JAMA
; 327(5): 432-441, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029629
7.
Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593-606, Sep/Oct 2018, DOI: 10.1002/pst.1873.
Pharm Stat
; 18(3): 278-281, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30932340
8.
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.
Cell Metab
; 7(1): 68-78, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18177726
9.
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles.
Sci Rep
; 13(1): 12784, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550377
10.
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.
Open Forum Infect Dis
; 10(12): ofad598, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111750
11.
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial.
Nat Med
; 29(10): 2615-2624, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37770652
12.
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.
Sci Transl Med
; 15(723): eadd4897, 2023 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992152
13.
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
JAMA Netw Open
; 5(8): e2225411, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969402
14.
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Int J Infect Dis
; 122: 585-592, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788416
15.
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Lancet Infect Dis
; 22(10): 1444-1454, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803290
16.
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
medRxiv
; 2021 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159343
17.
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.
medRxiv
; 2021 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159344
18.
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes.
BMC Endocr Disord
; 10: 7, 2010 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20412573
19.
Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib.
Br J Clin Pharmacol
; 66(6): 811-7, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18823299
20.
Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin.
Clin Pharmacol Drug Dev
; 4(5): 337-45, 2015 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27137142